By placing drug safety at the forefront, the World Drug Safety Congress Europe serves as a vital bridge, fostering communication and collaboration between international regulatory bodies, life sciences community and patient representatives. The event will delve into cutting-edge topics such as harnessing the potential of big data and artificial intelligence in pharmacovigilance, evaluating benefit-risk management strategies, and embracing patient-centric approaches.

Visit our booth # 63 to chat with our experts and discuss how you can do better with AI.